ivWatch
PrivateLast Round
Seed Round
Jan 26, 2024
Total Funding Raised
$19.8M
Company Overview
ivWatch is a medical device company that provides a continuous monitoring solution for the early detection of peripheral IV infiltrations and extravasations.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ivWatch Comps
Public and private peers based on sector, stage, and business model.
ivWatch Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jan 26, 2024 | ||||
| VC Round | Nov 22, 2019 | ||||
| Series B | Jun 7, 2017 | ||||
| VC Round | Mar 24, 2014 | ||||
| VC Round | Apr 16, 2013 | ||||
VC Round | Dec 22, 2011 |
Key People
Founding team and executive leadership
ivWatch Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| 757 Angels | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 26, 2024
$14.4M raised in Seed Round.
ivWatch Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ivWatch's valuation, stock price, and market status.
